Anika Therapeutics Inc (ANIK)
28.39
+0.55
(+1.98%)
USD |
NASDAQ |
May 07, 16:00
28.39
0.00 (0.00%)
After-Hours: 17:09
Anika Therapeutics Cash from Financing (Quarterly): 0.342M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.342M |
| September 30, 2023 | -0.11M |
| June 30, 2023 | -4.943M |
| March 31, 2023 | -1.613M |
| December 31, 2022 | 0.667M |
| September 30, 2022 | -4.611M |
| June 30, 2022 | -0.046M |
| March 31, 2022 | -0.862M |
| December 31, 2021 | 0.06M |
| September 30, 2021 | -6.982M |
| June 30, 2021 | 0.594M |
| March 31, 2021 | -0.451M |
| December 31, 2020 | -28.11M |
| September 30, 2020 | -25.18M |
| June 30, 2020 | 49.66M |
| March 31, 2020 | -0.141M |
| December 31, 2019 | 0.278M |
| September 30, 2019 | 21.70M |
| June 30, 2019 | -30.00M |
| March 31, 2019 | -0.119M |
| December 31, 2018 | -0.055M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | -27.63M |
| March 31, 2018 | -1.223M |
| December 31, 2017 | 0.004M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.101M |
| June 30, 2017 | 0.168M |
| March 31, 2017 | 0.041M |
| December 31, 2016 | 0.019M |
| September 30, 2016 | 0.066M |
| June 30, 2016 | 0.254M |
| March 31, 2016 | -24.33M |
| December 31, 2015 | -0.878M |
| September 30, 2015 | 0.049M |
| June 30, 2015 | 0.005M |
| March 31, 2015 | 1.898M |
| December 31, 2014 | 1.065M |
| September 30, 2014 | -0.0539M |
| June 30, 2014 | -1.183M |
| March 31, 2014 | 5.504M |
| December 31, 2013 | -8.186M |
| September 30, 2013 | 2.161M |
| June 30, 2013 | -0.4262M |
| March 31, 2013 | 0.7617M |
| December 31, 2012 | -0.3473M |
| September 30, 2012 | -0.1589M |
| June 30, 2012 | -0.3614M |
| March 31, 2012 | 0.1087M |
| December 31, 2011 | -0.1171M |
| September 30, 2011 | -0.40M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-30.00M
Minimum
Jun 2019
49.66M
Maximum
Jun 2020
-1.566M
Average
-0.141M
Median
Mar 2020
Cash from Financing (Quarterly) Benchmarks
| The Cooper Companies Inc | 212.30M |
| Staar Surgical Co | 0.367M |
| OrthoPediatrics Corp | 9.387M |
| NexGel Inc | 0.294M |
| Innovative Eyewear Inc | -0.4902M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 3.638M |
| Cash from Investing (Quarterly) | -1.84M |
| Free Cash Flow | -7.215M |
| Free Cash Flow Per Share (Quarterly) | 0.1228 |
| Free Cash Flow to Equity (Quarterly) | 1.798M |
| Free Cash Flow to Firm (Quarterly) | 1.798M |
| Free Cash Flow Yield | -1.73% |